Sun, MedImmune end dispute on Ethyol drug

Sun, MedImmune end dispute on Ethyol drug

New Delhi:Sun Pharmaceutical Industries Ltd, India biggest drug maker by market value, said the company and its subsidiaries settled a lawsuit with MedImmune Inc. on a generic version of the cancer drug Ethyol.

MedImmune granted Sun a licence to certain patents allowing the Indian company to continue to sell the generic version in the US, the Mumbai-based company said in a statement to the Bombay Stock Exchange on Monday.

Close